Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.
Cerrano M, Bonifacio M, Olivi M, Curti A, Malagola M, Dargenio M, Scattolin AM, Papayannidis C, Forghieri F, Gurrieri C, Tanasi I, Zappasodi P, La Starza R, Fracchiolla NS, Chiusolo P, Giaccone L, Del Principe MI, Giglio F, Defina M, Favre C, Rizzari C, Castella B, Pizzolo G, Ferrara F, Chiaretti S, Foà R.
Cerrano M, et al. Among authors: del principe mi.
Haematologica. 2022 Apr 1;107(4):996-999. doi: 10.3324/haematol.2021.279851.
Haematologica. 2022.
PMID: 35021604
Free PMC article.
No abstract available.